Technical specification
Wristworn wearable family of products which is able to measure ECG
and health metrics, also having the well-known fitness functions
The market advantage is that it is not a smartwatch using pulse oxymetry, but an advanced ECG microchip technology measuring accurate data and giving useful purpose for the user.
Able to measure clinically accurate ECG signal, therefor we can make relevant analysis.
Main function is ECG measurement and analys, so the device necessarily needs to obtain medical CE or FDA certification. The products are made accordingly, this guarantees quality and reliability.
In the frames of a monthly subscription service we monitor the users’ ECG waveform changes. The service sends a notice or alert when the risk of stroke or sudden cardiac death is elevated.
Our service covers the most common health problem: cardiac deseases. Currently there is no wide-spred and affordable technology to monitor and prevent above mentioned risks.
We will be able to provide a health monitoring service which could be spred in large customer base.
The system runs the analysis with intelligent learning algorithms that are more efficient than human methods.
We store the measured data on a personal timeline which is soon to form a huge medical BigData.
ECG-I Measuring Device
Innovation to Indicate the Risk of Stroke and Sudden Cardiac Death
Our development implements – based on previous other researches – one bipolar ECG lead (ECG-I) measuring method for Ventricular Heterogeneity and Atrial Fibrillation risk assessment.
Among other existing mobile and wearable ECG technologies, our development is capable of detecting clean filtered ECG signal, evaluating the results of the measurement immediately, and the risk of sudden cardiac death and stroke can be automatically predicted and concluded. The previously performed measurement results, other cardiac and vital signs are compared to the individual’s health status to ensure the algorithm-based remote cardiac evaluation.
